20403 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom; Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
PDK4 as a Cell-Aging Intervention Target and Its Use in Chemotherapy and Anticancer
#2MODULATORS OF RAR RELATED ORPHAN RECEPTORS (RORs)
#3PROTEIN PHOSPHATASE 2A ACTIVATORS
#4PRALATREXATE AND COP COMBINATION FOR THE TREATMENT OF PATIENTS WITH PERIPHERAL T CELL LYMPHOMA
#5ANTI-C5 ANTIBODY/C5 IRNA DOSING REGIMENS FOR TREATING C5-ASSOCIATED DISEASES
#6DRUG DELIVERY METHODS AND COMPOSITIONS
#7BRUSH PRODRUGS AND USES THEREOF
#8METHOD OF TREATING CANCER
#9CELL THERAPY COMPOSITIONS AND METHODS OF USE THEREOF
#10COMBINATION THERAPIES
#11LIPOSOMAL FORMULATION AND USE IN A COMBINATION PRODUCT AS AN ANTI-TUMOUR THERAPY
#12COMBINATION THERAPY FOR A RAS RELATED DISEASE OR DISORDER
#13ULTRASOUND MEDIATED DELIVERY OF DRUGS
#14APPLICATION METHOD OF BRUCINE FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS
#15USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#16AMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF
#17ENANTIOMER OF AZOPODOPHYLLOTOXIN DERIVATIVE SU056
#18Compositions and Methods for Treating Cancer
#19METHODS FOR LIPID NANOPARTICLE DELIVERY OF CRISPR/CAS SYSTEM
#20Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
#21CANCER TREATMENT AGENT INCLUDING MALT1 INHIBITING DRUG AS ACTIVE INGREDIENT
#22BETA CARBOLINE ANALOGUES AS SELECTIVE AND BIASED KAPPA OPIOID RECEPTORS AGONISTS FOR TREATING VARIOUS ASSOCIATED PATHOPHYSIOLOGICAL CONDITIONS
#23METHODS OF TREATING PANCREATIC CANCER WITH A PD-1 AXIS BINDING ANTAGONIST AND AN RNA VACCINE
#24SYSTEMS AND METHODS FOR SYMPATHETIC CARDIOPULMONARY NEUROMODULATION
#25PHARMACEUTICAL COMPOSITION FOR PREVENTION, ALLEVIATION, OR TREATMENT OF CANCER
#26EZH1/2 DUAL INHIBITOR-CONTAINING PHARMACEUTICAL COMPOSITION TO BE USED AS A COMBINATION DRUG
#27METHOD FOR PRETREATING RELAPSING CANCER
#28ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE
#29METHODS, COMPOSITIONS AND COMPOUNDS FOR TREATING AGE-RELATED DISEASES AND CONDITIONS
#30METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS
#31Vaporized Medicants and Methods of Use
#32CRIPTO-POSITIVE LIPID VESICLES FOR USE IN THE THERAPEUTIC TREATMENT OF AGGRESSIVE TUMOURS
#33Multifunctional Nanoparticles and Uses in Managing Cancer and Cardiovascular Diseases
#34COMBINATIONS OF KRAS G12D INHIBITORS WITH IRINOTECAN AND RELATED METHODS OF TREATMENT
#35ANABOLIC DRUGS STIMULATING TYPE II COLLAGEN PRODUCTION FROM CHONDROCYTES OR THEIR PROGENITORS
#36COMBINATION DRUG FOR TREATING MALIGNANT TUMOR
#37METHODS OF TREATING BREAST CANCER
#38METHODS FOR PREDICTING RESPONSIVENESS OF LYMPHOMA TO DRUG AND METHODS FOR TREATING LYMPHOMA
#39TRIPLEX NANOPARTICLES
#40ALBUMIN CONJUGATES AND RADIOPHARMACEUTICAL COMPOSITION THEREOF
#41COMBINATION THERAPY COMPRISING ANTI-CCR9 ANTIBODY AND VINCRISTINE FOR CANCER
#42PLANT TISSUE-DERIVED NANOFIBRES
#43COMBINATION TREATMENT OF AN ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODY AND CHEMOTHERAPY IN CTDNA HIGH RISK PATIENTS
#44TREATMENT OF HODGKIN LYMPHOMA USING AN ANTI-PD-1 ANTIBODY
#45Compound, Pharmaceutical Composition Comprising the Same and Method for Treating Cancer Using the Same
#46USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#47APPARATUS, METHODS, AND SYSTEMS FOR PROVIDING PHARMACEUTICAL COMPOSITIONS IN THE FORM OF DROPLETS FOR AEROSOL ADMINISTRATION AND INHALATION DELIVERY
#48PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
#49BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF
#50MODULATORS OF RAR-RELATED ORPHAN RECEPTORS (RORs)
#51P53 PEPTIDOMIMETIC MACROCYCLES
#52COMPOSITIONS AND METHODS FOR USE OF EFLORNITHINE AND DERIVATIVES AND ANALOGS THEREOF TO TREAT CANCERS, INCLUDING GLIOMAS
#53AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY
#54ADENOVIRUS DELIVERY SYSTEM FOR CANCER TREATMENT
#55Combination Therapies with Anti-CD38 Antibodies
#56LIQUID PREPARATION AND PREPARATION METHOD THEREFOR, AEROSOL GENERATION SYSTEM, CARTRIDGE FOR AEROSOL GENERATION SYSTEM, AND AEROSOL GENERATION APPARATUS
#57METHODS AND COMPOSITIONS FOR THE TREATMENT OF DRUG OVERDOSE
#58SUSTAINED-RELEASE GEL WITH INSOLUBLE SALT AS PH ADJUSTER, PREPARATION METHOD AND APPLICATION THEREOF
#59ASSESSING AND TREATING MULTIPLE MYELOMA
#60EPOXY STEROIDS
#61THIOL-BASED MULTIVALENT DRUG DELIVERY COMPOSITIONS
#62Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
#63COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT
#64SULFONAMIDE COMPOUNDS AND THE USE THEREOF IN THE TREATMENT OF CANCER
#65METHODS OF REDUCING NEUROPATHY AND NEUROPATHIC SYMPTOMS AND TREATING CANCER
#66BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR TREATING DIFFUSE LARGE B-CELL LYMPHOMA
#67SUCCINIC ACID AND DERIVATIVES FOR THE TREATMENT OF HAEMOTOLOGICAL DISORDERS
#68SEQUENTIAL INNATE AND ADAPTIVE IMMUNE MODULATION FOR CANCER TREATMENT
#69COMBINATION THERAPY FOR TREATING CANCER
#70METHODS OF TREATING CANCERS HAVING A DEREGULATED NRF2/KEAP1 PATHWAY
#71CELL-PENETRATING ANTI-DNA ANTIBODIES AND USES THEREOF INHIBIT DNA REPAIR
#72AMINONAPHTHOQUINONE COMPOUNDS AND PHARMACEUTICAL COMPOSITION FOR BLOCKING UBIQUITINATION-PROTEASOME SYSTEM IN DISEASES
#73Apparatus, methods, and systems for providing pharmaceutical compositions and administering medications to patients
#74TETRAHYDRO-1H-PYRIDO[3,4-b]INDOLE ANTI-ESTROGENIC DRUGS
#75METHODS OF TREATING B-CELL LYMPHOMA USING COMBINATION THERAPY
#76AEROSOL-FORMING SUBSTRATE AND AEROSOL-GENERATING SYSTEM
#77COMBINATION THERAPY WITH A VINCA ALKALOID N-OXIDE AND AN IMMUNE CHECKPOINT INHIBITOR
#78TETRAHYDRO-1H-PYRIDO[3,4-b]INDOLE ANTI-ESTROGENIC DRUGS
#79FUNCTIONALIZED 1,3-BENZENE DIOLS AND THEIR METHOD OF USE FOR THE TREATMENT OF INFLAMMATION AND PAIN
#80MINIMALLY TOXIC PRODRUGS
#81USE OF CANCER CELL EXPRESSION OF CADHERIN 12 AND CADHERIN 18 TO TREAT MUSCLE INVASIVE AND METASTATIC BLADDER CANCERS
#82Enhanced Anti-Proliferative and Antitumor Immune Effects of Mitochondria-Targeted Hydroxyurea
#83BRUCINE GEL PLASTER AND PREPARATION METHOD AND USE THEREOF
#84SMALL MOLECULAR DRUG-LOADED POLYMER VESICLE, PREPARATION METHOD THEREFOR AND USE THEREOF
#85ENHANCING CHEMOTHERAPY IN MEDULLOBLASTOMA AND GLIOBLASTOMA WITH HIGH BASAL p53 LEVELS
#86IMPROVED INDUSTRIAL PROCESS FOR EXTRACTION OF ALPHA YOHIMBINE FROM RAUWOLFIA SPECIES AND THE EXTRACT THEREOF
#87INHIBITOR OF CELL PROLIFERATION IN OBINUTUZUMAB RESISTANT CD20-POSITIVE CANCER, AND MEDICINAL COMPOSITION, MEDICINE, PRODUCTION, METHOD FOR INHIBITING CELL PROLIFERATION, THERAPEUTIC METHOD, TYPE II ANTI-CD20 ANTIBODY, COMPOUNDS, COMBINATION OF SAME, ENHANCER AND INDUCER, EACH RELATING THERETO
#88COMPOSITIONS AND METHODS FOR IMPROVED TREATMENT OF PLATINUM-BASED CHEMOTHERAPEUTIC RESISTANT TUMORS
#89COMBINATION THERAPY FOR TREATING CANCER
#90PRODRUGS OF 6-MERCAPTOPURINE
#91USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME AND CYCLOPHOSPHAMIDE, VINCRISTINE AND PREDNISONE
#92SETDB1-MICROTUBULE INTERACTION AND USE THEREOF
#93COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING CANCER
#94USE OF NGF ANTIBODY IN CIPN PAIN
#95USE OF IRAK4 MODULATORS FOR GENE THERAPY
#96COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING CANCER
#97METHOD FOR TREATING ALS/FTD THROUGH DEGRADATION OF RNA REPEAT EXPANSION
#98CONJUGATES OF ACTIVE PHARMACEUTICAL INGREDIENTS
#99CELL THERAPY COMPOSITIONS AND METHODS OF USE THEREOF
#100TOPOTECAN FOR PROLIFERATIVE VITREORETINOPATHY
#101Exosomal compositions and methods for the treatment of disease
#102PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
#103AMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF
#104USE OF CANNABINOIDS IN TREATING ANTI-DEPRESSANT-INDUCED FEMALE SEXUAL DYSFUNCTION
#105METHOD OF TREATING CANCER
#106DRUG-LOADED POLYMER VESICLE HAVING ASYMMETRIC MEMBRANE STRUCTURE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN PREPARATION OF DRUGS FOR TREATING ACUTE MYELOID LEUKEMIA
#107CYCLIC COMPOUNDS FOR USE IN TREATING RETINAL DEGENERATION
#108METHOD FOR TREATING A GD2-POSITIVE CANCER
#109USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#110PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
#111PROTEIN-DRUG CONJUGATES COMPRISING CAMPTOTHECIN ANALOGS AND METHODS OF USE THEREOF
#112USE OF A DHODH INHIBITOR COMPOUND IN COMBINATION CANCER THERAPY
#113OCULAR IMPLANT CONTAINING AN ACTIVE INGREDIENT
#114COMPOUNDS FOR CHRONIC DISORDERS
#115Methods and Compositions for Treating a Disease Condition in a Subject
#116POLYPEPTIDE THAT SPECIFICALLY BINDING TO CD123 PROTEIN, POLYPEPTIDE COMPLEXE, CO-DELIVERY SYSTEM AND PREPARATION METHOD AND USE THEREOF
#117Synchronizing Tumor Cells to the G2/M Phase Using TTFields Combined with Taxane or Other Anti-Microtubule Agents
#118USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#119IL-8 INHIBITORS FOR USE IN THE TREATMENT OF SOME SARCOMAS
#120EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
#121METHOD OF USING HIGH-FREQUENCY SOUND WAVES
#122Vaporized medicants and methods of use
#123A TREATMENT APPROACH INVOLVING KIF18A INHIBITION FOR CHROMOSOMALLY UNSTABLE TUMORS
#124Method for Treating CD127-Positive Cancers by Administering an Anti-CD127 Agent
#125COMBINATION CANCER THERAPY WITH DYRK1 INHIBITORS AND INHIBITORS OF THE RAS-RAF-MEK-ERK (MAPK) PATHWAY
#126EMBOLIZING AGENT PRECURSOR PHARMACEUTICAL COMPOSITION
#127METHOD OF IMAGING
#128EDIBLE PLANT EXOSOME-LIKE NANOVECTORS FOR VACCINATION
#129PRODUCTS FOR SUPPRESSING OR REDUCING THE EXPRESSION OR ACTIVITY OF A SNORNA AND USES THEREOF IN THE TREATMENT OF CANCER
#130Liposomes Useful for Drug Delivery
#131USE OF NOREPINEPHRINE OR BETA-ADRENERGIC RECEPTOR INHIBITOR IN PREPARATION OF MEDICAMENT FOR NERVE INJURY REPAIR IN DIABETES
#132VCP/p97 INHIBITOR FOR THE TREATMENT OF CANCER
#133METHODS FOR SOLID TUMOR TREATMENT
#134Method For Treating Pancreatic Cancer
#135Bacterial DNA gyrase inhibitors and methods of use thereof
#136Non-adult human dosing of anti-CD30 antibody-drug conjugates for treatment of hematological or lymphoid cancer
#137CAR AND NRF2 DUAL ACTIVATOR AGENTS FOR CYCLOPHOSPHAMIDE-BASED AND DOXORUBICIN-BASED TREATMENTS OF CANCER
#138Methods for treating multidrug resistant breast cancer
#139METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS
#140GLYPICAN-3-SPECIFIC MODIFIED APTAMER AND USE THEREOF
#141DILEUCINE COMPOSITIONS AND METHODS OF USE THEREOF FOR FAT LOSS
#142COMBINATION THERAPIES AND BIOMARKERS FOR TREATING CANCER
#143Composition and method for preventing, alleviating or treating cancer
#144COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING CANCER
#145Compositions for Inhibition of Herpesviruses
#146COMPOUNDS AND USES THEREOF
#147Combination therapy for cancer treatment
#148TISSUE DOSING FOR INTRALUMINAL LOCAL DRUG DELIVERY
#149Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
#150STENT
#151COMPOSITIONS AND METHODS FOR TREATMENT OF PATHOLOGIC PAIN ASSOCIATED WITH MALIGNANT GROWTH DISORDER
#152NON-AQUEOUS SUSTAINED RELEASE DRUG DELIVERY SYSTEM
#153NANOBOWL-SUPPORTED DRUG-LOADED LIPOSOME, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#154N-(FURAN-2-YLMETHYL)-7H-PURIN-6-AMINE FOR TREATMENT OF CIRCADIAN RHYTHM DISEASES, DISORDERS AND DYSFUNCTIONS
#155METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS
#156METHODS FOR TREATING DISEASES BY TARGETING ONCOGENIC LIPIDS
#157COMPOSITION COMPRISING LISURIDE COMPOUND FOR TREATING FRAGILE X SYNDROME OR RELATED DEVELOPMENTAL DISORDERS
#158TREATMENTS FOR DIFFUSE LARGE B-CELL LYMPHOMA
#159MITOTHERAPEUTICS FOR THE TREATMENT OF BRAIN DISORDERS
#160DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#161SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME
#162COMBINATION THERAPY FOR TREATING CANCER
#163PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
#164COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING IL-2 SURFACE EXPRESSION-EXTRACELLULAR VESICLES AS ACTIVE INGREDIENT
#165COMBINATIONS OF LSD1 INHIBITORS FOR USE IN THE TREATMENT OF SOLID TUMORS
#166DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODY
#167BRUSH PRODRUGS AND USES THEREOF
#168Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs
#169COMPOSITIONS AND ARTICLES COMPRISING (NANO)DIAMOND PARTICLES
#170THERAPEUTIC NANOPARTICLES FOR THE TREATMENT OF NEUROBLASTOMA AND OTHER CANCERS
#171INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#172LUNG TARGETED ANTICANCER THERAPIES WITH LIPOSOMAL ANNAMYCIN
#173COMBINATIONS OF LSD1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES
#174BRUCINE GEL FORMULATION AND PREPARATION METHOD THEREFOR
#175P-GP INDUCERS AS PROTECTORS AGAINST CHEMOTHERAPY-INDUCED SIDE EFFECTS, SUCH AS PERIPHERAL NEUROPATHY (CIPN) AND HAIR LOSS
#176METHODS FOR REDUCING TUMOR PROGRESSION AND FIBROSIS AND INCREASING ADAPTIVE IMMUNITY IN MALIGNANCIES
#177PARAXANTHINE-BASED COMPOSITIONS FOR PROMOTING WEIGHT LOSS
#178ANTI-CTLA4-ANTI-PD-1 BISPECIFIC ANTIBODY AND USES THEREOF
#179CHOLECYSTOKININ B RECEPTOR TARGETING FOR IMAGING AND THERAPY
#180Use of koumine in preparation of medicament for treatment of inflammatory bowel disease
#181ANTI-PD-1 ANTIBODY AND MEDICAL USE THEREOF
#182COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE
#183Drug delivery methods and compositions
#184P2X7 RECEPTOR TARGETED THERAPY
#185Cancer cell-targeted drug delivery carrier and composition for promoting photo-thermal treatment effects, both of which contain M1 macrophages as active ingredient
#186COMPOSITIONS AND METHODS FOR TREATING LUNG, COLORECTAL AND BREAST CANCER
#187BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF
#188USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#189Enhancing chemotherapy in medulloblastoma and glioblastoma with high basal p53 levels
#190ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF PREVIOUSLY TREATED BREAST CANCER
#191METHODS OF TREATING CANCER
#192COMBINATION TREATMENT OF SPECIFIC FORMS OF EPILEPSY
#193QUINOLINE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR TREATING EWING'S SARCOMA
#194ANTI-CD19 COMBINATION THERAPY
#195EZH2 inhibitors for treating lymphoma
#196USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#197CANNABINOID COMPOSITIONS AND USE THEREOF
#198Bispecific antibody against CD3 and CD20 in combination therapy for treating diffuse large B-cell lymphoma
#199MODIFIED IL-12 T CELL THERAPY FOR THE TREATMENT OF CANCER
#200PREPARING LIPOSOMES WITH HIGH DRUG LOADING CAPACITY AND THE USE THEREOF
#201TARGETED POLYMERIZED NANOPARTICLES FOR CANCER TREATMENT
#202ANALOGUES OF OLEUROPEIN AND OLEACEIN AND USES THEREOF
#203COMBINATIONS FOR THE TREATMENT OF NEOPLASMS USING QUIESCENT CELL TARGETING AND INHIBITORS OF MITOSIS
#204METHODS FOR TREATING CHEMORESISTANT CANCER-INITIATING CELLS
#205PSMA binding ligand-linker conjugates and methods for using
#206Pharmaceutical compounds and therapeutic methods
#207PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
#208KLOTHO BETA
#209SUBCONJUNCTIVAL CHEMOTHERAPEUTIC DELIVERY BY FIBRIN SEALANT IN THE TREATMENT OF RETINOBLASTOMA
#210ESTROGEN RECEPTOR PROTEIN DEGRADERS
#211LIGAND-DRUG-CONJUGATES AS SUBSTRATES FOR SELECTIVE CLEAVAGE BY THE EXOPEPTIDASE ACTIVITY OF CATHEPSIN B
#212Crystalline forms of a quinazoline compound and its hydrochloride salts
#213Bone Morphogenetic Protein Pathway Activation, Compositions for Ossification, and Methods Related Thereto
#214TREATMENT OF ADULT T CELL LEUKEMIA/LYMPHOMA (ATLL) USING MIR-155 INHIBITORS
#215Inhibition of thymine DNA glycosylase in the treatment of cancer
#216KITS AND METHODS FOR TREATING CANCERS
#217TREATMENT OF HODGKIN LYMPHOMA USING AN ANTI-PD-1 ANTIBODY
#218Small molecule prolactin receptor inhibitors, pharmaceutical compositions and treatment methods using such inhibitors
#219Plant tissue-derived nanofibres
#220CELL-PENETRATING ANTI-DNA ANTIBODIES AND USES THEREOF INHIBIT DNA REPAIR
#221Application of Chidamide in combination with R-CHOP, and drug combination
#222Combined treatment of primary central nervous system lymphoma
#223Pharmaceutical Composition for Treating B-Cell Lymphoma
#224MODULATORS OF RAR-RELATED ORPHAN RECEPTORS (RORs)
#225Treatment and prevention of premature ejaculation (PE)
#226EZH1/2 DUAL INHIBITOR-CONTAINING PHARMACEUTICAL COMPOSITION TO BE USED AS A COMBINATION DRUG
#227TARGETING THE TRANSCRIPTION FACTOR NF-KB WITH HARMINE
#228Site-specific conjugation of linker drugs to antibodies and resulting ADCs
#229BRUSH PRODRUGS AND USES THEREOF
#230Drug combinations for use in the treatment of RAS-mutant cancer
#231NANOPARTICLE FORMULATIONS AND METHODS OF USE FOR ALPHA CONNEXIN C-TERMINAL PEPTIDES
#232USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
#233IL-8 inhibitors for use in the treatment of some sarcomas
#234METHODS OF TREATING CANCERS HAVING A DEREGULATED NRF2/KEAP1 PATHWAY
#235MICROCARRIER FOR EMBOLIZATION AND PREPARATION METHOD THEREFOR
#236Methods of Treating Cancer
#237Allele specific modulators of P23H rhodopsin
#238Methods and compositions for treatment of glaucoma and related conditions
#239PSMA binding ligand-linker conjugates and methods for using
#240DESIGN AND DEVELOPMENT OF NEUROKININ-1 RECEPTOR-BINDING AGENT DELIVERY CONJUGATES
#241THERAPY FOR NEUROLOGICAL DISEASES/DISORDERS
#242GEMCITABINE PRODRUGS
#243NOVEL STRAINS HAVING EFFECTS OF PREVENTING OR TREATING CANCERS
#244COMPOSITIONS AND METHODS FOR TREATING CANCER
#245PSMA binding ligand-linker conjugates and methods for using
#246Basic chemotherapeutic intratumour injection formulation
#247COMPOUNDS AND METHODS FOR CSK MODULATION AND INDICATIONS THEREFOR
#248Dosage form of vinca alkaloid drug
#249Combination of cannabinoids in the treatment of leukemia
#250ULTRASOUND MEDIATED DELIVERY OF DRUGS
#251KLOTHO BETA
#252Use of cannabinoids in treating anti-depressant-induced female sexual dysfunction
#253Use of an ABC transporter peptide inhibitor
#254CANCER TREATMENT METHODS
#255METHODS OF USING REBASTINIB IN THE TREATMENT OF DISORDERS
#256NANOPARTICLE FORMULATIONS OF IKE AND METHODS OF USE THEREOF
#257SUCCINIC ACID AND DERIVATIVES FOR THE TREATMENT OF HAEMOTOLOGICAL DISORDERS
#258USE OF AVERMECTIN DERIVATIVE FOR INCREASING BIOAVAILABILITY AND EFFICACY OF MACROCYLIC LACTONES
#259Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
#260Enhancing chemotherapy in medulloblastoma and glioblastoma with high basal p53 levels
#261Use of manzamines as antiproliferative agent
#262EDIBLE PLANT EXOSOME-LIKE NANOVECTORS FOR VACCINATION
#263METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS
#264PYRVINIUM PAMOATE THERAPIES AND METHODS OF USE
#265TAXANE-LIPID-POLYSACCHARIDE DUAL CONJUGATES, PREPARATION METHODS THEREOF AND USES THEREOF
#266Methods of reducing side effects of anti-CD30 antibody drug conjugate therapy
#267A METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER
#268THIOL-BASED MULTIVALENT DRUG DELIVERY COMPOSITIONS
#269Treatment for reducing adverse events including chemotherapy discomfort and other conditions
#270Composition comprising a therapeutic agent and a CXCR4 selective antagonist and methods for using the same
#271SETBP1 inhibitors for the treatment of myeloid neoplasms and solid tumors
#272TARGETED DELIVERY OF HYDROPHILIC DRUGS TO LUNG
#273Use of inhibitors of Brutons tyrosine kinase (Btk)
#274Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity
#275Vaporized medicants and methods of use
#2765-LIPOXYGENASE ANTAGONISTS
#277METHOD OF USING CHECKPOINT KINASE INHIBITOR THERAPY TO MODULATE ANTI-TUMORAL RESPONSE AGAINST CANCER AND SENSITIZE GLIOMAS TO IMMUNOTHERAPY
#278COMBINATION OF POZIOTINIB WITH CYTOTOXIC AGENT AND/OR OTHER MOLECULARLY TARGETED AGENT AND USE THEREOF
#279Furoquinolinediones as inhibitors of TDP2
#280Conjugates of active pharmaceutical ingredients
#281Strains having effects of preventing or treating cancers
#282METHODS OF IDENTIFYING MYC-DRIVEN AND LIPOGENESIS-DEPENDENT NEOPLASMS AND METHODS OF TREATING THE SAME
#283Composition for preventing or treating metastatic ovarian cancer, endometrial cancer or breast cancer
#284Liposomes Useful for Drug Delivery
#285Aminopyrimidine amide autophagy inhibitors and methods of use thereof
#286WEAKLY BASIC DRUG AND IONIC POLYMER PHARMACEUTICAL FORMULATIONS AND METHODS OF FORMATION AND ADMINISTRATION THEREOF
#287Substituted fused heteroaromatic tricyclic compounds as kinase inhibitors and the use thereof
#288Methods and Compositions for Treating a Disease Condition in a Subject
#289DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#290Combination therapy for treating cancer
#291Methods of treating or preventing fibrosis in non-alcoholic fatty liver disease
#292INHIBITION OF ZSCAN4 FOR INHIBITION OF TUMOR GROWTH
#293METHOD OF TREATING CANCER
#294PSMA binding ligand-linker conjugates and methods for using
#295MICRORNA 584-5P COMPOSITIONS AND METHODS FOR TREATING CANCER
#296Nutritional product and method of using it
#297Combination therapies with anti-CD38 antibodies
#298Combination therapy for treating cancer
#299ANTICANCER AGENT
#300Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs